参考文献/References:
[1] American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Clinical management guidelines for obstetriciangynecologists. Number 30, September 2001(replaces Technical Bulletin Number 200, December 1994). Gestational diabetes[J].Obstet Gynecol, 2001,98(3):525-538.
[2] Fukuhara A, M atsuda M, Nishizawa M, et al Visfatin a protein secreted by visceral fat that minics the effects of insulin [J].Science, 2005, 307(5708): 426-430.
[3] Sonoli SS, Shivprasad S, Prasad CV, et al. Visfatin--a review[J].Eur Rev for Med Pharmacol Sci, 2011,15(1): 9-14.
[4] Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals[J].Curr Opin Gastroenterol, 2007, 23(2): 164-170.
[5] Filippatos TD, Derdemezis CS, Gazi IF, et al. Increased plasma visfatin levels in subjects with the metabolic syndrome[J].Eur J Clin Invest, 2008, 38(1): 71-72.
[6] Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis[J].J Clin Invest, 2004, 113(9): 1318-1327.
[7] Saddi-Rosa P, Oliveira CS, Giuffrida FM, et al. Visfatin, glucose metabolism and vascular disease: a review of evidence[J].Diabetol Metab Syndr, 2010, 2: 21.
[8] Lehrke M, Lazar MA. The many faces of PPARgamma[J].Cell, 2005, 123(6): 993-999.
[9] Mayi TH, Rigamonti E, Pattou F, et al. Liver X Receptor(LXR)activation negatively regulates visfatin expression in macrophages[J].Biochem Biophy Res Commun, 2011, 404(1): 458-462.
[10] Choi KC, Ryu OH, Lee K W. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats[J].Biochem Biophy Res Commun,2005, 36(3): 747-753.
[11] Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care, 2010,33(3):676-682.
[12] de Kreutzenberg SV, Ceolotto G, Papparella I, et al. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms[J].Diabetes, 2010,59(4):1006-1015.
[13] Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes[J].Nature, 2007,450(7170):712-716.
[14] Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex[J].J Biol Chem,2006,281(52):39915-39924.
[15] Ramachandran D, Roy U, Garg S, et al. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets[J].FEBS J, 2011,278(7):1167-1174.
[16] Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme[J]. Cell Metab, 2007, 6: 363-375.
[17] Telejko B, Kuzmicki M, Zonenberg A, et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue[J].Diabetes Res Clin Pract, 2009,84(1):68-75.
[18] Ma Y, Cheng Y, Wang J, et al. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes[J].Diabetes Res Clin Pract, 2010, 90(1): 60-65.
[19] 罗佳茜,刘兴会,张力等. Visfatin在妊娠期糖尿病患者胎盘组织中的表达及意义[J]. 四川大学学报(医学版)2011, 42(2): 204-207.
[20] Mayi TH, Duhem C, Copin C, et al.Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages[J]. FEBS J, 2010, 277(17): 3308-3320.
[21] Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma(PPAR gamma)[J]. J Biol Chem, 1995, 270(22): 12953-12956.
[22] Li L, Yang GY, Shi SC, et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-a(TNF-a)in vivo[J]. Cytokine, 2009, 45(1): 12-19.
相似文献/References:
[1]乔艳花,张丹丹,王倩.妊娠糖尿病与甲状腺自身免疫的相关性研究[J].国际内分泌代谢杂志,2015,(04):242.[doi:10.3760/cma.j.issn.1673-4157.2015.04.007]
Qiao Yanhua,Zhang Dandan,Wang Qian..Relationship between gestational diabetes and thyroid autoimmunity[J].International Journal of Endocrinology and Metabolism,2015,(05):242.[doi:10.3760/cma.j.issn.1673-4157.2015.04.007]
[2]王锐 陆强 王术艺 朱东林 蒋韬 马宁 刘悦 李燕莉
贾晓娇 姚立新.血清25羟维生素D及vaspin水平与妊娠糖尿病关系的研究[J].国际内分泌代谢杂志,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
Wang Rui,Lu Qiang,Wang Shuyi,et al.Relationship between serum 25-hydroxyvitamin D, vaspin and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
[3]李晶,董荣娜,于德民.有氧运动对胰岛素抵抗小鼠visfatin
表达的影响[J].国际内分泌代谢杂志,2016,36(01):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
Li Jing,Dong Rongna,Yu Demin..Effects of aerobic exercise on the expression of visfatin in mice with insulin resistance[J].International Journal of Endocrinology and Metabolism,2016,36(05):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
[4]曹琳,刘超.妊娠糖尿病诊疗的争议与共识[J].国际内分泌代谢杂志,2016,36(03):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]
Cao Lin,Liu Chao..Controversy and concensus on the diagnosis and treatment of gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]